| Endostar (recombinant human endostatin) / Simcere |
NCT00657423: Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC) |
|
|
| Unknown status | 3 | 80 | RoW | Treated by endostar combined with docetaxel and cisplatin, Endostar, Taxotere, Treated by docetaxel and cisplatin | Xijing Hospital, Yantai Medgenn Ltd. | Lung Neoplasms | 12/08 | 04/09 | | |
NCT02283476: The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. |
|
|
| Unknown status | 3 | 200 | RoW | Endostar continuous intravenous infusion, Endostar routine intravenous infusion, Gemcitabine, Cisplatin | Jiangsu Simcere Pharmaceutical Co., Ltd. | Lung Cancer | 11/17 | 11/17 | | |
NCT04914598: A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions |
|
|
| Not yet recruiting | 3 | 290 | RoW | ENDOSTAR，cisplatin, Placebo , cisplatin | Jiangsu Simcere Pharmaceutical Co., Ltd. | Malignant Pleural Effusion | 06/22 | 10/23 | | |
EXECC, NCT03577392: Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer. |
|
|
| Unknown status | 2/3 | 120 | RoW | oxaliplatin + capecitabine (XELOX chemotherapy), rebombniant human endostatin | Sichuan Provincial People's Hospital, Jiangsu Simcere Pharmaceutical Co., Ltd. | Quality of Life | 08/19 | 08/21 | | |
NCT03588494: Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer |
|
|
| Unknown status | 2/3 | 318 | RoW | concurrent chemoradiotherapy (CCRT), Endostar for one cycle, Endostar for two cycles | Affiliated Hospital of North Sichuan Medical College, Jiangsu Simcere Pharmaceutical Co., Ltd. | Quality of Life | 09/19 | 09/21 | | |
